Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial

Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Enrollment updated to 477 participants across 89 locations; many site locations and contact details were removed.
    Difference
    5%
    Check dated 2026-03-28T03:44:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Gūrgaon, India and Naples, Italy as study locations and included a new publication citation (Oaknin A, Lee JY, Makker V, Oh DY, Banerjee S, Gonzalez-Martin A, Jung KH, Lugowska I, Manso L, Manzano A, Melichar B, Siena S, Stroyakovskiy D, Fielding A, Puvvada S, Smith A, Meric-Bernstam F. Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02. Adv Ther. 2024 Nov;41(11):4125-4139. doi: 10.1007/s12325-024-02975-x. Epub 2024 Sep 11.) with Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T01:17:42.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The recruitment location entry was updated from Gūrgaon, India, 122001 to Gurgaon, India, 122001.
    Difference
    0.0%
    Check dated 2026-03-13T19:53:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added study site Gūrgaon, India (122001) to the Locations list and updated the revision from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:07:18.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Gurgaon, India, 122001 as a location and removed Gūrgaon, India, 122001 as a location.
    Difference
    0.0%
    Check dated 2026-02-27T19:09:16.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2, a minor label change with no impact on page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:59:07.000Z thumbnail image

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.